Concepedia

Adam Sherwat

AS

Statistics

Publications

10

Citations

812

H-Index

10

Active since

2012

Affiliations

Center for Drug Evaluation and Research(Current)

National Institute of Allergy and Infectious Diseases

Office of Infectious Diseases

Fred Hutch Cancer Center

New York Blood Center

Adam Sherwat is an author at Center for Drug Evaluation and Research specializing in antiviral therapy, pharmacotherapy, and infectious diseases.

Publications per year

2012–2022

10

Publications

10

FDA Approval of Remdesivir — A Step in the Right Direction

Daniel B. Rubin, Kirk M. Chan‐Tack, John Farley et al. · New England Journal of Medicine · 2020 · 224 citations · Full text

, , +13

Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

Spyros A. Kalams, Scott Parker, Marnie Elizaga et al. · The Journal of Infectious Diseases · 2013 · 197 citations · Full text

, , +17

Tecovirimat and the Treatment of Monkeypox — Past, Present, and Future Considerations

Adam Sherwat, John T. Brooks, Debra Birnkrant et al. · New England Journal of Medicine · 2022 · 171 citations

, , +6

Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

Mark D. Gershman, J. Erin Staples, Adwoa Bentsi-Enchill et al. · Vaccine · 2012 · 68 citations · Full text

, , +5

Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir

Takashi Komatsu, Sarita D. Boyd, Adam Sherwat et al. · Gastroenterology · 2016 · 57 citations

, , +12

1–5 of 10